What medication should be noted for potential interaction with a new ACE inhibitor prescription?

The medication that should be noted for potential interaction with a new ACE inhibitor prescription is a potassium supplement. ACE inhibitors are known to interfere with the regulation of potassium levels in the body, often leading to increased potassium levels (hyperkalemia). This is particularly important in patients who are already taking potassium supplements, as the combined effect can elevate potassium levels to dangerously high levels.

Monitoring potassium levels is critical when starting an ACE inhibitor, especially if the patient is also using potassium supplements. Preventing hyperkalemia is essential, as it can lead to serious cardiac complications. Therefore, it's crucial for healthcare providers to be aware of any potassium supplementation when prescribing ACE inhibitors to manage the risk effectively.

The other medications listed do not have a direct and significant interaction with ACE inhibitors concerning potassium levels, which is why the focus is appropriately on potassium supplements in this context.